J&J reports 2014 fourth-quarter results

Johnson & Johnson announced sales of $18.3 billion for the fourth quarter of 2014, a decrease of 0.6% as compared to the fourth quarter of 2013.

izcgdbqvy

Mr Alex Gorsky, chairman and CEO, J&J (Photo Courtesy: www.bloomberg.com)

Operational results increased 3.9 percent and the negative impact of currency was 4.5 percent.

Domestic sales increased 7.4 percent. International sales decreased 6.7 percent, reflecting operational growth of 1.2 percent and a negative currency impact of 7.9 percent.

Excluding the net impact of acquisitions and divestitures, on an operational basis, worldwide sales increased 6.7 percent, domestic sales increased 10.7 percent and international sales increased 3.6 percent.

Worldwide sales for the full-year 2014 were $74.3 billion, an increase of 4.2 percent versus 2013. Operational results increased 6.1 percent and the negative impact of currency was 1.9 percent.

Domestic sales increased 9.0 percent. International sales increased 0.4 percent, reflecting operational growth of 3.7 percent and a negative currency impact of 3.3 percent.

 

Previous 1 Next

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X